Mecka | $60,000,000 | (Jun 3, 2026)
Novellia | $18,000,000 | (Jun 3, 2026)
Plot | $10,000,000 | (Jun 3, 2026)
Proprio
United States
- Seattle, WA
- 28/07/2023
- Series B
- $43,000,000
Proprio is a medical technology company based in Seattle, Washington. We create the new way of seeing™ in surgery through a proprietary platform of artificial intelligence, computer vision, and augmented/virtual reality. Our goal is to significantly improve patient outcomes and surgeon wellbeing through the collaboration of physician expertise and immersive, intelligent technology. We work closely with industry-leading medical and technical advisors and reputable research institutions specializing in neurosurgery, medical devices, AI, computer vision, and robotics to dimensionalize and digitize surgical vision in groundbreaking, real-time applications. A quickly-growing, award-winning company, our team consists of creative, diverse, multi-disciplinary thinkers and innovators who value designing technology for positive and unprecedented social and industry impact.
- Industry Medical Equipment Manufacturing
- Website https://www.propriovision.com/
- LinkedIn https://www.linkedin.com/company/proprio-vision/
Related People
Gabriel JonesCo Founder
United States -
ND
Entrepreneur and business leader in technology and medicine with 20+ year track record in strategy, business development, marketing and product development. ~$40M raised from Seed to Commercialization stages.
There is nothing more motivating to me than a product that excites and empowers the user. When technology is nearly invisible, when it just works, that's when we know we've got it right.
KOSMOS | $5,000,000 | (Jun 3, 2026)
Phosio Corporation | $4,000,000 | (Jun 3, 2026)
StratusGrid | $3,000,000 | (Jun 3, 2026)
Subtle Medical | $33,000,000 | (Jun 3, 2026)
Tavo Biotherapeutics | $17,000,000 | (Jun 3, 2026)
Contraline | $92,500,000 | (Jun 3, 2026)
Gigaton | $26,000,000 | (Jun 3, 2026)
Westmag | $11,000,000 | (Jun 3, 2026)
Inherent | $50,000,000 | (Jun 2, 2026)